Board of Directors

Andrew Levin, PhD, MD
Partner and Managing Director,
RA Capital Management

Andrew Levin is a Partner on the Investment Team at RA Capital Management. His primary responsibilities are to build and invest in early-stage private companies across biotech, healthcare technologies, and services.

Previously he served as a Vice President at H.I.G. BioVentures and Director of Pharmaceutical Sciences at the Clinton Health Access Initiative.

Andrew holds a BSE in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD. from Harvard Medical School.